BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol 2017;31:239-47. [PMID: 28774405 DOI: 10.1016/j.bpg.2017.05.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol 2022; 28(29): 3793-3802 [DOI: 10.3748/wjg.v28.i29.3793] [Reference Citation Analysis]
2 Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281 [DOI: 10.3748/wjg.v28.i21.2251] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Flores JE, Thompson AJ, Ryan M, Howell J. The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma. Vaccines 2022;10:793. [DOI: 10.3390/vaccines10050793] [Reference Citation Analysis]
4 Yang S, Wang S, Du M, Liu M, Liu Y, He Y. Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis. Infect Dis Ther 2022. [PMID: 35471766 DOI: 10.1007/s40121-022-00638-4] [Reference Citation Analysis]
5 He C, He H, Sun C, Ojha SC, Wang H, Deng C, Sheng Y. The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.03.014] [Reference Citation Analysis]
6 Sagnelli C, Pisaturo M, Curatolo C, Codella AV, Coppola N, Sagnelli E. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic. World J Gastroenterol 2021; 27(42): 7271-7284 [PMID: 34876788 DOI: 10.3748/wjg.v27.i42.7271] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Stevenson C, Youn JH, Hayney MS, David C. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine. Hum Vaccin Immunother 2021;:1-11. [PMID: 34505827 DOI: 10.1080/21645515.2021.1965807] [Reference Citation Analysis]
8 Souda S, Mwita JC, Cainelli F, Mannathoko NB, Anderson M, Moyo S. Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study. Southern African Journal of Infectious Diseases 2021;36. [DOI: 10.4102/sajid.v36i1.275] [Reference Citation Analysis]
9 Zhang Q, Yang L, Liu S, Zhang M, Jin Z. Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma. Front Immunol 2021;12:645835. [PMID: 34177894 DOI: 10.3389/fimmu.2021.645835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wei Y, Zhao Z, Wang Z, Zhang K, Tang Z, Tao C. Relationships between IL-1β, TNF-α genetic polymorphisms and HBV infection: A meta-analytical study. Gene 2021;791:145617. [PMID: 33775848 DOI: 10.1016/j.gene.2021.145617] [Reference Citation Analysis]
11 Zeleke ED, Assefa DG, Joseph M, Bekele D, Tesfahunei HA, Getachew E, Manyazewal T. Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis of randomised control trials. Rev Med Virol 2021;:e2216. [PMID: 33483986 DOI: 10.1002/rmv.2216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Miranda NTGP, de Souza RL, Monteiro JC, Costa IB, Siravenha LQ, da Luz ALB, de Almeida NCC, Oliveira-Filho AB, Laurentino RV, Machado LFA. Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Pará, northern Brazil. J Med Virol 2021;93:3730-7. [PMID: 33368401 DOI: 10.1002/jmv.26759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Deng H, Fan X, Wang X, Zeng L, Zhang K, Zhang X, Li N, Han Q, Lv Y, Liu Z. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Sci Rep 2020;10:20276. [PMID: 33219288 DOI: 10.1038/s41598-020-77332-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Girawan D, Judistiani RTD, Risan NA, Bestari MB, Nugraha ES, Ermaya YS, Prasetyo D. The High Prevalence of Negative Hepatitis B Surface Antibody (Anti-HBs) among Pregnant Women in Bandung, Indonesia: A Community-Based Study. Int J Hepatol 2020;2020:3414869. [PMID: 33133698 DOI: 10.1155/2020/3414869] [Reference Citation Analysis]
15 Chevalier-Cottin EP, Ashbaugh H, Brooke N, Gavazzi G, Santillana M, Burlet N, Tin Tin Htar M. Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases. Infect Dis Ther 2020;9:467-80. [PMID: 32583334 DOI: 10.1007/s40121-020-00312-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ogawa E, Yeo YH, Dang N, Le MH, Jeong D, Tran S, Henry L, Cheung R, Nguyen MH. Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States. JAMA Netw Open 2020;3:e201844. [PMID: 32271388 DOI: 10.1001/jamanetworkopen.2020.1844] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
17 Lampertico P, Buti M, Fung S, Ahn SH, Chuang WL, Tak WY, Ramji A, Chen CY, Tam E, Bae H, Ma X, Flaherty JF, Gaggar A, Lau A, Liu Y, Wu G, Suri V, Tan SK, Subramanian GM, Trinh H, Yoon SK, Agarwal K, Lim YS, Chan HLY. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. Lancet Gastroenterol Hepatol 2020;5:441-53. [PMID: 32087795 DOI: 10.1016/S2468-1253(19)30421-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 26.0] [Reference Citation Analysis]
18 Joshi SS, Coffin CS. Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics. Hepatol Commun. 2020;4:157-171. [PMID: 32025602 DOI: 10.1002/hep4.1460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
19 Zhao N, Jia B, Zhao H, Xu J, Sheng X, Luo L, Huang Z, Wang X, Ren Q, Zhang Y, Zhao X, Cui Y. A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers. Antimicrob Agents Chemother. 2019;64. [PMID: 31636065 DOI: 10.1128/aac.01686-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
20 Tramontano E, Corona A, Menéndez-Arias L. Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. Antiviral Res 2019;171:104613. [PMID: 31550450 DOI: 10.1016/j.antiviral.2019.104613] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
21 Lim SG, Agcaoili J, De Souza NNA, Chan E. Therapeutic vaccination for chronic hepatitis B: A systematic review and meta-analysis. J Viral Hepat. 2019;26:803-817. [PMID: 30801899 DOI: 10.1111/jvh.13085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
22 Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC. Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B. Hepatology 2019;69:959-73. [PMID: 30175482 DOI: 10.1002/hep.30246] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
23 Gill US, Kennedy PTF. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics. J Viral Hepat 2018. [DOI: 10.1111/jvh.13040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
24 Chen E, Ma Y, Wang J, He F, Zhou T, Ji Y, Tang H. Prevalence of hepatitis B virus infection in western China: epidemiological survey results of general adult population. Future Virology 2018;13:629-36. [DOI: 10.2217/fvl-2018-0051] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zare Marzouni H, Davachi B, Rezazadeh M, Salehi Milani M, Matinfard S. Diagnostic Value of Hepatic Vein Ultrasound in Early Detection of Liver Cirrhosis. Galen Med J 2018;7:e1140. [PMID: 34466440 DOI: 10.22086/gmj.v0i0.1140] [Reference Citation Analysis]
26 Ghaswalla PK, Patterson BJ, Cheng WY, Duchesneau E, Macheca M, Duh MS. Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis. Hum Vaccin Immunother 2018;14:2780-5. [PMID: 29923789 DOI: 10.1080/21645515.2018.1489189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
27 da Rocha MC, Marinho RT, Rodrigues T. Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012. GE Port J Gastroenterol 2018;25:123-31. [PMID: 29761148 DOI: 10.1159/000484868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
28 Mokhtari AM, Moghadami M, Seif M, Mirahmadizadeh A. Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran. Iran J Med Sci 2021;46:93-102. [PMID: 33753953 DOI: 10.30476/ijms.2019.83112.1199] [Reference Citation Analysis]